Literature DB >> 27049734

Chemical and semisynthetic approaches to study and target deubiquitinases.

Pushparathinam Gopinath1, Shimrit Ohayon1, Mickal Nawatha1, Ashraf Brik1.   

Abstract

Ubiquitination is a key posttranslational modification, which affects numerous biological processes and is reversed by a class of enzymes known as deubiquitinases (DUBs). This family of enzymes cleaves mono-ubiquitin or poly-ubiquitin chains from a target protein through different mechanisms and mode of interactions with their substrates. Studying the role of DUBs in health and diseases has been a major goal for many laboratories both in academia and in industry. However, the field has been challenged by the difficulties in obtaining native substrates and novel reagents using traditional enzymatic and molecular biology approaches. Recent advancements in the synthesis and semisynthesis of proteins made it possible to prepare several unique ubiquitin conjugates to study various aspects of DUBs such as their specificities and structures. Moreover, these approaches enable the preparation of novel activity based probes and assays to monitor DUB activities in vitro and in cellular contexts. Efforts made to bring new chemical entities for the selective inhibition of DUBs based on these tools are also highlighted with selected examples.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27049734     DOI: 10.1039/c6cs00083e

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  20 in total

Review 1.  Chemoenzymatic Semisynthesis of Proteins.

Authors:  Robert E Thompson; Tom W Muir
Journal:  Chem Rev       Date:  2019-11-27       Impact factor: 60.622

2.  De novo macrocyclic peptides that specifically modulate Lys48-linked ubiquitin chains.

Authors:  Mickal Nawatha; Joseph M Rogers; Steven M Bonn; Ido Livneh; Betsegaw Lemma; Sachitanand M Mali; Ganga B Vamisetti; Hao Sun; Beatrice Bercovich; Yichao Huang; Aaron Ciechanover; David Fushman; Hiroaki Suga; Ashraf Brik
Journal:  Nat Chem       Date:  2019-06-10       Impact factor: 24.427

3.  Selective macrocyclic peptide modulators of Lys63-linked ubiquitin chains disrupt DNA damage repair.

Authors:  Ganga B Vamisetti; Abhishek Saha; Yichao J Huang; Rajeshwer Vanjari; Guy Mann; Julia Gutbrod; Nabieh Ayoub; Hiroaki Suga; Ashraf Brik
Journal:  Nat Commun       Date:  2022-10-18       Impact factor: 17.694

4.  Identification and validation of selective deubiquitinase inhibitors.

Authors:  Anthony C Varca; Dominick Casalena; Wai Cheung Chan; Bin Hu; Robert S Magin; Rebekka M Roberts; Xiaoxi Liu; He Zhu; Hyuk-Soo Seo; Sirano Dhe-Paganon; Jarrod A Marto; Douglas Auld; Sara J Buhrlage
Journal:  Cell Chem Biol       Date:  2021-06-14       Impact factor: 9.039

5.  Understanding and predicting the potency of ROS-based enzyme inhibitors, exemplified by naphthoquinones and ubiquitin specific protease-2.

Authors:  Pushparathinam Gopinath; Atif Mahammed; Shimrit Ohayon; Zeev Gross; Ashraf Brik
Journal:  Chem Sci       Date:  2016-08-05       Impact factor: 9.825

Review 6.  Activity-based probes for the ubiquitin conjugation-deconjugation machinery: new chemistries, new tools, and new insights.

Authors:  David S Hewings; John A Flygare; Matthew Bogyo; Ingrid E Wertz
Journal:  FEBS J       Date:  2017-03-10       Impact factor: 5.542

7.  Ubiquitin carboxyl-terminal hydrolase isozyme L5 inhibits human glioma cell migration and invasion via downregulating SNRPF.

Authors:  Jiafeng Ge; Weiwei Hu; Hui Zhou; Juan Yu; Chongran Sun; Weilin Chen
Journal:  Oncotarget       Date:  2017-12-07

8.  Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes.

Authors:  Wioletta Rut; Mikolaj Zmudzinski; Scott J Snipas; Miklos Bekes; Tony T Huang; Marcin Drag
Journal:  Chem Sci       Date:  2020-05-27       Impact factor: 9.825

Review 9.  Assay Systems for Profiling Deubiquitinating Activity.

Authors:  Jinhong Cho; Jinyoung Park; Eunice EunKyeong Kim; Eun Joo Song
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

Review 10.  Chemically Induced Cellular Proteolysis: An Emerging Therapeutic Strategy for Undruggable Targets.

Authors:  Seonghyeon Moon; Byung-Hoon Lee
Journal:  Mol Cells       Date:  2018-11-07       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.